Cargando…
Research on the Effects of the Chronic Treatment With Different Doses of Urocortin 2 in Heart Failure Rats
Corticotropin-releasing factor (CRF) receptor type 2 (CRF(2)) exists in both cardiomyocytes and neurocytes. The purpose of this research was to explore if chronic treatment with urocortin 2 (UCN2), a CRF(2) receptor agonist, at different doses can improve prognosis and regulate the expression of CRF...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595674/ https://www.ncbi.nlm.nih.gov/pubmed/31263386 http://dx.doi.org/10.1177/1559325819860018 |